Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells

Stem Cell Research

Volumn 15, Issue 1, 2015, Pages 254-262

  Trokovic, Ras ^a   Weltner, Jere ^a   Noisa, Parinya ^b,c   Raivio, Taneli ^b,d   Otonkoski, Timo ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c SURANAREE UNIVERSITY OF TECHNOLOGY   (Thailand)

^d UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; DONOR AGE; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; INFANT; MALE; MIDDLE AGED; NEWBORN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL CULTURE; UPREGULATION; VERY ELDERLY; YOUNG ADULT; CELL CULTURE; CYTOLOGY; DONOR; INDUCED PLURIPOTENT STEM CELL; METABOLISM; RETROVIRIDAE; SENDAI VIRUS; TIME FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED, 80 AND OVER; CELLS, CULTURED; CELLULAR REPROGRAMMING; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROVIRIDAE; SENDAI VIRUS; TIME FACTORS; TISSUE DONORS; YOUNG ADULT;

EID: 84939464377     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2015.06.001     Document Type: Article

References (49)

1. Banito A., Rashid S.T., Acosta J.C., Li S., Pereira C.F., Geti I., Pinho S., Silva J.C., Azuara V., Walsh M., Vallier L., Gil J. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 2009, 23(18):2134-2139.
2. Braam S.R., Tertoolen L., Casini S., Matsa E., Lu H.R., Teisman A., Passier R., Denning C., Gallacher D.J., Towart R., Mummery C.L. Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. Stem Cell Res. 2013, 10(1):48-56.
3. Brown J.P., Wei W., Sedivy J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997, 277(5327):831-834.
4. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8(9):729-740.
5. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002, 30(10):e47.
6. Choudhury A.R., Ju Z., Djojosubroto M.W., Schienke A., Lechel A., Schaetzlein S., Jiang H., Stepczynska A., Wang C., Buer J., Lee H.W., von Zglinicki T., Ganser A., Schirmacher P., Nakauchi H., Rudolph K.L. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat. Genet. 2007, 39(1):99-105.
7. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75(4):817-825.
8. Eminli S., Foudi A., Stadtfeld M., Maherali N., Ahfeldt T., Mostoslavsky G., Hock H., Hochedlinger K. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet. 2009, 41(9):968-976.
9. Esteban M.A., Wang T., Qin B., Yang J., Qin D., Cai J., Li W., Weng Z., Chen J., Ni S., Chen K., Li Y., Liu X., Xu J., Zhang S., Li F., He W., Labuda K., Song Y., Peterbauer A., Wolbank S., Redl H., Zhong M., Cai D., Zeng L., Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010, 6(1):71-79.
10. Hanna J., Saha K., Pando B., van Zon J., Lengner C.J., Creyghton M.P., van Oudenaarden A., Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462(7273):595-601.
11. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P., Dobrowolski S., Bai C., Connell-Crowley L., Swindell E., et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 1995, 6(4):387-400.
12. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., Okita K., Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009, 460(7259):1132-1135.
13. Hou P., Li Y., Zhang X., Liu C., Guan J., Li H., Zhao T., Ye J., Yang W., Liu K., Ge J., Xu J., Zhang Q., Zhao Y., Deng H. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341(6146):651-654.
14. Hussein S.M., Batada N.N., Vuoristo S., Ching R.W., Autio R., Narva E., Ng S., Sourour M., Hamalainen R., Olsson C., Lundin K., Mikkola M., Trokovic R., Peitz M., Brustle O., Bazett-Jones D.P., Alitalo K., Lahesmaa R., Nagy A., Otonkoski T. Copy number variation and selection during reprogramming to pluripotency. Nature 2011, 471(7336):58-62.
15. Jackson J.G., Pereira-Smith O.M. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. Cancer Res. 2006, 66(17):8356-8360.
16. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B., Raya A., Wahl G.M., Belmonte J.C. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460(7259):1140-1144.
17. Lapasset L., Milhavet O., Prieur A., Besnard E., Babled A., Ait-Hamou N., Leschik J., Pellestor F., Ramirez J.M., De Vos J., Lehmann S., Lemaitre J.M. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 2011, 25(21):2248-2253.
18. Li H., Collado M., Villasante A., Strati K., Ortega S., Canamero M., Blasco M.A., Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009, 460(7259):1136-1139.
19. Li Y., Feng H., Gu H., Lewis D.W., Yuan Y., Zhang L., Yu H., Zhang P., Cheng H., Miao W., Yuan W., Cheng S.Y., Gollin S.M., Cheng T. The p53-PUMA axis suppresses iPSC generation. Nat. Commun. 2013, 4:2174.
20. Mali P., Ye Z., Hommond H.H., Yu X., Lin J., Chen G., Zou J., Cheng L. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 2008, 26(8):1998-2005.
21. Marión R.M., Strati K., Li H., Murga M., Blanco R., Ortega S., Fernandez-Capetillo O., Serrano M., Blasco M.A. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460(7259):1149-1153.
22. Marion R.M., Strati K., Li H., Tejera A., Schoeftner S., Ortega S., Serrano M., Blasco M.A. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4(2):141-154.
23. Mondello C., Petropoulou C., Monti D., Gonos E.S., Franceschi C., Nuzzo F. Telomere length in fibroblasts and blood cells from healthy centenarians. Exp. Cell Res. 1999, 248(1):234-242.
24. Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113(6):703-716.
25. Nishimura K., Sano M., Ohtaka M., Furuta B., Umemura Y., Nakajima Y., Ikehara Y., Kobayashi T., Segawa H., Takayasu S., Sato H., Motomura K., Uchida E., Kanayasu-Toyoda T., Asashima M., Nakauchi H., Yamaguchi T., Nakanishi M. Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J. Biol. Chem. 2011, 286(6):4760-4771.
26. Park S.J., Yeo H.C., Kang N.Y., Kim H., Lin J., Ha H.H., Vendrell M., Lee J.S., Chandran Y., Lee D.Y., Yun S.W., Chang Y.T. Mechanistic elements and critical factors of cellular reprogramming revealed by stepwise global gene expression analyses. Stem Cell Res. 2014, 12(3):730-741.
27. Qin H., Yu T., Qing T., Liu Y., Zhao Y., Cai J., Li J., Song Z., Qu X., Zhou P., Wu J., Ding M., Deng H. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J. Biol. Chem. 2007, 282(8):5842-5852.
28. Rasmussen M.A., Holst B., Tumer Z., Johnsen M.G., Zhou S., Stummann T.C., Hyttel P., Clausen C. Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage. Stem Cell Rep. 2014, 3(3):404-413.
29. Seki T., Yuasa S., Oda M., Egashira T., Yae K., Kusumoto D., Nakata H., Tohyama S., Hashimoto H., Kodaira M., Okada Y., Seimiya H., Fusaki N., Hasegawa M., Fukuda K. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010, 7(1):11-14.
30. Smith Z.D., Nachman I., Regev A., Meissner A. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat. Biotechnol. 2010, 28(5):521-526.
31. Somers A., Jean J.C., Sommer C.A., Omari A., Ford C.C., Mills J.A., Ying L., Sommer A.G., Jean J.M., Smith B.W., Lafyatis R., Demierre M.F., Weiss D.J., French D.L., Gadue P., Murphy G.J., Mostoslavsky G., Kotton D.N. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010, 28(10):1728-1740.
32. Song B., Sun G., Herszfeld D., Sylvain A., Campanale N.V., Hirst C.E., Caine S., Parkington H.C., Tonta M.A., Coleman H.A., Short M., Ricardo S.D., Reubinoff B., Bernard C.C. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. Stem Cell Res. 2012, 8(2):259-273.
33. Streckfuss-Bomeke K., Wolf F., Azizian A., Stauske M., Tiburcy M., Wagner S., Hubscher D., Dressel R., Chen S., Jende J., Wulf G., Lorenz V., Schon M.P., Maier L.S., Zimmermann W.H., Hasenfuss G., Guan K. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur. Heart J. 2013, 34(33):2618-2629.
34. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
35. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
36. Trokovic R., Weltner J., Manninen T., Mikkola M., Lundin K., Hamalainen R., Suomalainen A., Otonkoski T. Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts. Stem Cells Dev. 2013, 22(1):114-123.
37. Trokovic R., Weltner J., Nishimura K., Ohtaka M., Nakanishi M., Salomaa V., Jalanko A., Otonkoski T., Kyttala A. Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells. Stem Cells Transl. Med. 2014, 12:1402-1409.
38. Trokovic R., Weltner J., Otonkoski T. Generation of iPSC line HEL24.3 from human neonatal foreskin fibroblasts. Stem Cell Res. 2015, 15:266-268.
39. Trokovic R., Weltner J., Otonkoski T. Generation of iPSC line HEL47.2 from healthy human adult fibroblasts. Stem Cell Res. 2015, 15:263-265.
40. Utikal J., Polo J.M., Stadtfeld M., Maherali N., Kulalert W., Walsh R.M., Khalil A., Rheinwald J.G., Hochedlinger K. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009, 460(7259):1145-1148.
41. Wang B., Miyagoe-Suzuki Y., Yada E., Ito N., Nishiyama T., Nakamura M., Ono Y., Motohashi N., Segawa M., Masuda S., Takeda S. Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages. PLoS Curr. 2011, 3:RRN1274.
42. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., Daley G.Q., Brack A.S., Collins J.J., Cowan C., Schlaeger T.M., Rossi D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7(5):618-630.
43. Wright W.E., Shay J.W. Telomere positional effects and the regulation of cellular senescence. Trends Genet. 1992, 8(6):193-197.
44. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366(6456):701-704.
45. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858):1917-1920.
46. Yu Y., Liu H., Ikeda Y., Amiot B.P., Rinaldo P., Duncan S.A., Nyberg S.L. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies. Stem Cell Res. 2012, 9(3):196-207.
47. Zhao R., Daley G.Q. From fibroblasts to iPS cells: induced pluripotency by defined factors. J. Cell. Biochem. 2008, 105(4):949-955.
48. Zhao Y., Yin X., Qin H., Zhu F., Liu H., Yang W., Zhang Q., Xiang C., Hou P., Song Z., Liu Y., Yong J., Zhang P., Cai J., Liu M., Li H., Li Y., Qu X., Cui K., Zhang W., Xiang T., Wu Y., Zhao Y., Liu C., Yu C., Yuan K., Lou J., Ding M., Deng H. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 2008, 3(5):475-479.
49. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., Trauger S., Bien G., Yao S., Zhu Y., Siuzdak G., Scholer H.R., Duan L., Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4(5):381-384.